2023 tables: Institutions - corporate

The 2023 tables are based on Nature Index data from 1 January 2022 to 31 December 2022. Changes in output from 2021 for the natural sciences can be viewed by using the subject/journals filter.

Table criteria

# Institution Share 2022 Count 2022
1 F. Hoffmann-La Roche AG, Switzerland 64.63 183
2 AstraZeneca plc, United Kingdom (UK) 45.62 175
3 Merck & Co., Inc., United States of America (USA) 41.57 116
4 Alphabet Inc., United States of America (USA) 34.56 88
5 Pfizer Inc., United States of America (USA) 32.78 109
6 IBM Corporation, United States of America (USA) 26.82 82
7 Novartis International AG, Switzerland 26.75 125
8 Samsung Group, South Korea 23.30 128
9 Johnson & Johnson, United States of America (USA) 22.68 88
10 Formosa Plastics Group, Taiwan 22.67 67
11 Regeneron Pharmaceuticals, Inc., United States of America (USA) 18.96 54
12 China State Shipbuilding Corporation Limited (CSSC), China 18.74 338
13 AbbVie Inc., United States of America (USA) 17.73 46
14 Eli Lilly and Company, United States of America (USA) 17.42 59
15 Bristol-Myers Squibb (BMS), United States of America (USA) 16.81 63
16 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 16.43 71
17 Nippon Telegraph and Telephone Corporation (NTT), Japan 14.59 34
18 BGI, China 14.22 58
19 Sanofi, France 13.77 47
20 FiberHome Technologies Group, China 13.56 124
21 Thermo Fisher Scientific Inc., United States of America (USA) 11.82 71
22 China Aerospace Science and Technology Corporation (CASC), China 10.33 61
23 Moderna, Inc., United States of America (USA) 10.32 25
24 Amgen Inc., United States of America (USA) 9.79 72
25 GNS Science, New Zealand 9.33 58
26 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 9.31 26
27 Bayer AG, Germany 8.49 51
28 Microsoft Corporation, United States of America (USA) 8.30 52
29 Gilead Sciences, Inc., United States of America (USA) 8.08 29
30 Takeda Pharmaceutical Company Limited, Japan 7.73 23
31 DowDuPont Inc., United States of America (USA) 7.69 33
32 BASF SE, Germany 7.48 35
33 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 7.31 34
34 Biogen Inc., United States of America (USA) 7.30 30
35 Leidos Holdings, Inc., United States of America (USA) 7.01 101
36 Novo Nordisk A/S, Denmark 6.54 47
37 Shanghai Qi Zhi Institute, China 6.48 43
38 Waters Corporation, United States of America (USA) 6.29 14
39 Sinopec Corporation, China 6.19 44
40 China National Petroleum Corporation (CNPC), China 6.08 29
41 Saudi Aramco, Saudi Arabia 6.06 16
42 Bruker Corporation, United States of America (USA) 5.91 38
43 China National Chemical Corporation (ChemChina), China 5.88 27
44 Techint Group, Italy 5.67 61
45 23andMe, Inc., United States of America (USA) 5.47 13
46 Toyota Group, Japan 5.47 19
47 Jinchuan Group Co., Ltd., China 5.39 19
48 Alibaba Group Holding Limited, China 4.98 61
49 Fresenius SE & Co. KGaA, Germany 4.69 50
50 China Electronics Technology Group Corporation (CETC), China 4.54 20
51 Alnylam Pharmaceuticals, Inc., United States of America (USA) 4.53 5
52 Vir Biotechnology, Inc., United States of America (USA) 4.30 18
53 Thales S.A., France 4.16 44
54 Institute of Environmental Science and Research (ESR), New Zealand 4.04 10
55 Sony Corporation, Japan 3.97 7
56 Total S.A., France 3.83 19
57 Abt Associates Inc., United States of America (USA) 3.79 20
58 National Institute of Water and Atmospheric Research Ltd. (NIWA), New Zealand 3.77 23
59 Nestlé S.A., Switzerland 3.73 9
60 Tencent, China 3.61 10
61 Norwegian Research Centre AS (NORCE), Norway 3.58 50
62 NanoString Technologies, Inc., United States of America (USA) 3.47 9
63 Science Systems and Applications, Inc. (SSAI), United States of America (USA) 3.47 28
64 Mitsubishi Group, Japan 3.45 16
65 Quantinuum Ltd., United States of America (USA) 3.35 4
66 Daiichi Sankyo Co., Ltd., Japan 3.33 17
67 New England Biolabs, Inc. (NEB), United States of America (USA) 3.31 10
68 Vertex Pharmaceuticals Incorporated, United States of America (USA) 3.30 11
69 Shionogi & Co., Ltd., Japan 3.21 16
70 State Grid Corporation of China (SGCC), China 3.17 14
71 Genomics England Ltd., United Kingdom (UK) 3.14 13
72 Mirati Therapeutics, Inc., United States of America (USA) 3.02 6
73 Robert Bosch GmbH, Germany 2.93 11
74 Enamine Ltd., Ukraine 2.89 8
75 Ionis Pharmaceuticals, Inc., United States of America (USA) 2.87 13
76 Tsinghua Unigroup, China 2.81 16
77 Rigaku Corporation, Japan 2.71 20
78 Foundation Medicine, Inc., United States of America (USA) 2.64 16
79 BioMarin Pharmaceutical, Inc., United States of America (USA) 2.61 8
80 Royal Dutch Shell plc (Shell), Netherlands 2.60 11
81 Hitachi, Ltd., Japan 2.49 15
82 NaMLab gGmbH, Germany 2.40 6
83 Panasonic Corporation, Japan 2.35 6
84 Murata Manufacturing Co., Ltd., Japan 2.33 8
85 Koninklijke Philips N.V. (Philips), Netherlands 2.33 20
86 China National Tobacco Company (CNTC), China 2.27 12
87 IVIRMA Global, Spain 2.26 8
88 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 2.22 10
89 Research Institutes of Sweden (RISE), Sweden 2.21 18
90 UCB S.A., Belgium 2.21 15
91 Adroit Materials, Inc., United States of America (USA) 2.20 6
92 IQM Finland Oy, Finland 2.17 3
93 Danaher Corporation, United States of America (USA) 2.15 7
94 BioNTech AG, Germany 2.10 7
95 Eisai Co., Ltd., Japan 2.08 12
96 China Aerospace Science and Industry Corp. (CASIC), China 2.08 12
97 STMicroelectronics N.V., Switzerland 2.06 10
98 Innovent Biologics, Inc., China 2.05 7
99 Intel Corporation, United States of America (USA) 2.04 13
100 ELI-HU Nonprofit Ltd., Hungary 2.02 11

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.